Molar Incisor HypomineralisationNCT07850986
Pain Assessment Governing Partial or Full Pulpotomy of Immature Molars With Irreversible Pulpitis in Molar Incisor Hypomineralization
A study testing pulpotomy for MIH affected immature PFMs, partial pulpotomy for MIH affected immature PFMs and pulpotomy for non-MIH affected immature PFMs in people with Molar Incisor Hypomineralisation and Irreversible Pulpitis, run by Alaa Khafagy at 1 site in Egypt.
Trial summary
This randomized controlled clinical trial aims to evaluate and compare pain levels associated with partial pulpotomy (PP) and full pulpotomy (FP) in immature permanent first molars diagnosed with irreversible pulpitis. Read more about this study
- Who is it for?
- Ages 6 to 8 yearsHealthy volunteers can take part
- Conditions the study is for
- Molar Incisor Hypomineralisation, Irreversible Pulpitis, Immature Molars
- What is being tested?
- pulpotomy for MIH affected immature PFMs, partial pulpotomy for MIH affected immature PFMs and pulpotomy for non-MIH affected immature PFMs
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 132 participants
- Where
- 1 siteEgypt
- Study dates
- 1 May 2026to 30 Oct 2026
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 8 years
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Age ranges from 6 - 8 years.
- Children free of any systemic disease or special health care need (ASA I).
- Positive or definitely positive behavior during preoperative assessments
- according to the Frankl Rating Scale (score 3 or 4).
- Patients whose parents will give their written consent to participate.
- MIH-affected PFMs with Treatment Need index (TNI) 4c).
Show all 16Show fewer
- Schiff Cold Air Sensitivity Scale (SCASS) scores 2 and 3.
- Restorable MIH-affected PFMs associated with signs and symptoms of irreversible pulpitis
- Spontaneous, unprovoked pain
- Lingering pain after thermal stimulus.
- Exacerbation by postural changes.
- Referred pain.
- Nocturnal pain.
- Haemostasis achieved within 10 minutes
- Negative response to percussion and palpation
- Restorable non-MIH-affected PFMs associated with signs and symptoms of irreversible pulpitis.
Who cannot join
- Medically compromised patients.
- Allergies to local anesthesia.
- Intolerance to NSAIDs.
- Patients with Frankl scores 1 and 2.
- Patients who took analgesics or antibiotics in the last 12 hours.
- Non-restorable permanent first molars.
Show all 14Show fewer
- Non-vital permanent first molars (negative response to pulp testing).
- Tooth mobility with grades 2 and 3.
- pocket depth greater than 5 mm.
- Radiographic evidence of vertical root fracture, perforation, and/or peri-apical radiolucency.
- Widening of periodontal ligament.
- Pain on percussion.
- Uncontrolled puplpal haemorrhage lasting more than 10 minutes
- Degenerating pulp
Trial locations and contacts
1 site in 1 country.
Egypt1 site
Faculty of Dentistry, Alexandria University
Alexandria, Alexandria Governorate, 555
About this study
Official title: Pain Assessment Governing Partial or Full Pulpotomy of Immature Molars With Irreversible Pulpitis in Molar Incisor Hypomineralization (a Randomized Controlled Clinical Trial)
This randomized controlled clinical trial aims to evaluate and compare pain levels associated with partial pulpotomy (PP) and full pulpotomy (FP) in immature permanent first molars diagnosed with irreversible pulpitis. The study specifically investigates differences between molars affected by molar incisor hypomineralization (MIH) and those without MIH.
A total of 132 children aged 6-8 years will be randomly allocated into four groups based on MIH status and type of pulpotomy. All participants will receive pre-emptive ibuprofen prior to treatment. Pain will be assessed preoperatively, intraoperatively, and postoperatively using validated scales.
The study aims to evaluate pre-, intra-, and postoperative pain levels after partial pulpotomy (PP) and full pulpotomy (FP) in MIH-affected immature permanent first molars (PFMs) with irreversible pulpitis.
Read the detailed description
This study is a four-arm, parallel-group, single-blinded randomized controlled clinical trial designed to evaluate pain associated with vital pulp therapy in immature permanent first molars (PFMs) diagnosed with irreversible pulpitis.
The trial will include 132 children aged 6 to 8 years presenting with either MIH-affected or non-MIH-affected immature PFMs requiring treatment. Eligible teeth will be stratified based on the presence of molar incisor hypomineralization (MIH), then randomly assigned to receive either full pulpotomy (FP) or partial pulpotomy (PP), resulting in four study groups:
- MIH + FP
- MIH + PP
- Non-MIH + FP
- Non-MIH + PP
All participants will receive pre-emptive analgesia using ibuprofen (25 mg/kg) one hour prior to treatment to enhance pain control.
The primary outcome is pain assessment at multiple time points: preoperative, intraoperative, and postoperative (4, 6, 12, 24, and 48 hours, and 1 week). Pain will be evaluated using the Wong-Baker Faces Pain Rating Scale (subjective) and FLACC scale (objective).
Secondary outcomes include:
- Patient cooperation assessed using the Frankl Behavioral Rating Scale
- Patient satisfaction assessed using a 5-point Likert scale
- Patient anxiety assessed objectively using pulse oximeter pre- and intraoperatively
All procedures will be performed under standardized clinical protocols using local anesthesia, rubber dam isolation, and biocompatible pulp capping materials. Final restorations will be completed using stainless steel crowns.
The study follows CONSORT guidelines and aims to provide evidence on the effectiveness of partial versus full pulpotomy in pain management, particularly in MIH-affected immature molars, where altered pulp characteristics may influence pain perception and treatment outcomes.
- Being tested
- pulpotomy for MIH affected immature PFMs, partial pulpotomy for MIH affected immature PFMs, pulpotomy for non-MIH affected immature PFMs, partial pulpotomy for non-MIH affected immature PFMs
- Keywords
- MIH-Affected Immature Molars, Irreversible Pulpitis, Pulpotomy, Partial Pulpotomy
- Medical subject headings
- Molar Hypomineralization
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
pulpotomy for MIH affected immature PFMsProcedure or surgery
Step-by-step pulpotomy procedure for MIH affected immature PFMs
partial pulpotomy for MIH affected immature PFMsProcedure or surgery
Step-by-step partial pulpotomy procedure for MIH affected immature PFMs
pulpotomy for non-MIH affected immature PFMsProcedure or surgery
Step-by-step pulpotomy procedure for non-MIH affected immature PFMs
partial pulpotomy for non-MIH affected immature PFMsProcedure or surgery
Step-by-step partial pulpotomy procedure for non-MIH affected immature PFMs
| Study group | Role | What they receive |
|---|---|---|
| Group IA (n=33) | Experimental | Step-by-step pulpotomy procedure for MIH affected immature PFMs Receives: Procedure: pulpotomy for MIH affected immature PFMs |
| Group IB (n=33) | Experimental | Step-by-step partial pulpotomy procedure for MIH affected immature PFMs Receives: Procedure: partial pulpotomy for MIH affected immature PFMs |
| Group IIA (n=33) | Active comparator | Step-by-step pulpotomy procedure for non-MIH affected immature PFMs Receives: Procedure: pulpotomy for non-MIH affected immature PFMs |
| Group IIB (n=33) | Active comparator | Step-by-step partial pulpotomy procedure for non-MIH affected immature PFMs Receives: Procedure: partial pulpotomy for non-MIH affected immature PFMs |
What is being measured
The primary outcome is the main question the study is designed to answer.
pain evaluation
To evaluate pre-, intra-, and postoperative pain levels after partial pulpotomy (PP) and full pulpotomy (FP) in MIH-affected immature permanent first molars (PFMs) with irreversible pulpitis using Wong-Baker's pain rating scale.
minimum value=0 better outcome maximum value=10 worse outcome
Measured: one week
Secondary outcomes (4)
pain comparison
To compare pain levels (pre-, intra-, and postoperative) between PP and FP in MIH-affected and non-MIH-affected immature PFMs with irreversible pulpitis using Wong-Baker's pain rating scale.
minimum=0 better outcome maximum=10 worse outcome
Measured: one week
patient satisfaction
To compare patient satisfaction after PP and FP in MIH-affected and non-MIH-affected immature PFMs with irreversible pulpitis using 5-point likert scale.
minimum (very dissatisfied) =0 maximum (very satisfied) =5
Measured: after 1 week
patient cooperation
To compare patient cooperation during PP and FP in MIH-affected and non-MIH-affected immature PFMs with irreversible pulpitis using Frankl scale.
minimum (definitely negative) (rating score 1) maximum (definitely positive) (rating scale 4)
Measured: 1 day
Patient anxiety
Evaluate physiological stress and anxiety preoperatively and intraoperatively objectively by recording heart rate using a pulse oximeter
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Oct 2026
- Study start1 May 2026
- Primary completion30 Oct 2026 (estimated)
- Study completion30 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Molar Incisor HypomineralisationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 132 participants (actual)
Sponsor and investigators
- Lead sponsor
- Alaa Khafagy
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Alaa Khafagy, Alexandria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07850986
- Sponsor's protocol ID
- 1225-01/2026
- Status last verified
- Sep 2026
- First submitted
- 20 Sep 2026
- Last updated
- 1 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No